These findings were supported by the clinical observation that the pericyte expression of HK2 was up-regulated in tumors as compared with normal adjacent tissues, while high percentage of pericyte-HK2 positive blood vessels correlated with poor overall survival in NSCLC and HCC patients respectively. The gene discussed is HK2; the disease is non-small cell lung carcinoma.